Markets
Delta Airlines Airbus A319 Portland Oregon.
A Delta Airbus A319 landing at PDX in bright evening sunlight.
Cyberstruck

The CrowdStrike fiasco wiped out $380 million of Delta revenue. Was it even worse than feared?

The six major airlines were expected to log a loss totalling $860 million due to the outage.

Yiwen Lu
10/10/24 12:29PM

The CrowdStrike outage cost Delta Air Lines $380 million in direct revenue loss for the three months that ended in September, according to Delta’s latest earnings report.

Earlier, insurer Parametrix estimated that Fortune 500 companies would suffer from a total financial loss of $5.4 billion from the outage. The airline industry was projected to be one of the most heavily impacted industries, with the six major airlines expected to log a $860 million loss. If that aligns with the actual number, Delta’s $380 million shortfall would account for almost half of the entire airline industry’s loss and around 7% of all Fortune 500 companies’ losses.

Delta was the most affected airline after the global IT outage in July, which hit about 8.5 million devices. The company was forced to cancel 7,000 flights over five days, according to its filings. Delta struggled even after rivals picked up normal operations; in comparison, United reportedly canceled 1,500 flights over a four-day period following the onset of the outage. 

During an earnings call before market open on Thursday, Delta blamed the outage for a 45-cent dip in earnings per share, which came in at $1.50 per share, less than analysts’ expectations. Revenue was also short of Wall Street estimates. 

Most of the revenue loss was driven by refunds and customer compensations. Reimbursement and crew expenses amounted to $170 million, or nearly half of the losses. CEO Ed Bastian told CNBC that Delta was seeking compensation from CrowdStrike and Microsoft

Shares of Delta fell 3.7% immediately after market open on Thursday and gradually bounced back during intraday trading, though it was still 1.3% down in early afternoon. CrowdStrike stock was up 3.3% as of 1:30 p.m. ET on Thursday.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.